Search
Welcome
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
Not a subscriber? Subscribe here
Register Now
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
                       
Careers & Tenders
Newsletters
Subscribe
The Mail & Guardian
      SUBSCRIBE / Support independent journalism                   CAREERS & TENDERS / Visit careers.mg.co.za                   WHATSAPP? / Follow the M&G WhatsApp channel here            
Login / Register

LOGIN

  • News
    • Africa
    • Business
    • Editorial
    • Education
    • Health
    • Motoring
    • National
    • Sci-tech
    • Sport
    • World
  • Thought Leader
  • Politics
  • Green Guardian
  • Friday
  • Features
    • Buthelezi, the King’s Hand
    • Cabinet Report Cards 2023
    • Cabinet Report Cards 2012-2021
    • The Fiscal Cliff
  • Research World
    • Submissions
    • Papers
  • 200 Young South Africans
  • Events
    • 200 Young South Africans
    • Greening The Future
    • Power Of Women
      • 2024 Edition
    • Critical Thinking Forum
    • Youth Summit
    • Webinars
  • More..
    • Partners
    • Podcasts
    • Crossword
    • Digital Editions
    • Register
    • WhatsApp Channel
    • Login
    • Lost Password

           

Pharmaceuticals

Fake medicines: South Africa’s silent epidemic
Thought Leader
/ 11 June 2025

Fake medicines: South Africa’s silent epidemic

There is an urgent need to prevent the proliferation of counterfeit and substandard pharmaceuticals

By Fentse Maseko
A prescription for Gauteng’s health: Generics, state pharma and the power of local
Thought Leader
/ 4 June 2025

A prescription for Gauteng’s health: Generics, state pharma and the power of local

Enabling the use of generics, supporting local businesses and setting up a state pharmaceutical company would boost healthcare

By Fentse Maseko
US aid cuts: Africa must make its own medicine
Thought Leader
/ 31 March 2025

US aid cuts: Africa must make its own medicine

Donald Trump’s funding freeze underlines that South Africa needs to prioritise the development of its pharmaceutical manufacturing sector

By Michael Mynhardt
Year-on-year growth in retail sales slows down in August compared with July
Business
/ 19 October 2022

Year-on-year growth in retail sales slows down in August compared with July

On a month-on-month basis retail trade sales decreased for the fourth consecutive month showing that consumers are still cash-strapped

By Anathi Madubela
It’s doable: Africa wants 60% of locally manufactured vaccines by 2040
Health
/ 17 December 2021

It’s doable: Africa wants 60% of locally manufactured vaccines by 2040

The next three to five years will require the continent to ensure there is sustainable business beyond Covid-19.

By Marcia Zali
Britain sets out plans for ‘no-deal’ Brexit
Article
/ 23 August 2018

Britain sets out plans for ‘no-deal’ Brexit

Document details contingency planning if Britain leaves the European Union in March with no transition deal

By Agency
Antidepressant pollutants make courting birds violent — study
Article
/ 10 August 2018

Antidepressant pollutants make courting birds violent — study

Male starlings sang less and were more aggressive towards females that had been given small doses of the antidepressant Fluoxetine

By Agency
Fighting the spread of fake drugs in Africa
Africa
/ 11 January 2018

Fighting the spread of fake drugs in Africa

The battle to eliminate fake pharmaceutical products is being stepped up

By Sella Oneko
National cancer drug shortage may last until October
Article
/ 23 June 2017

National cancer drug shortage may last until October

Pharmaceutical companies say that delayed drug registrations by the Medicines Control Council may have played a role in stock outs.

By Joan Van Dyk
Money can’t be the only motive for developing life-saving medicines
Article
/ 17 October 2016

Money can’t be the only motive for developing life-saving medicines

Will the world act now to be ready for the next big outbreak?

By Malebona Precious Matsoso
Activists lead fight for the right to cheaper drugs
Article
/ 7 April 2016

Activists lead fight for the right to cheaper drugs

There is a big move afoot to alert SADC members to the concessions on intellectual property rights that they can take advantage of.

By Amy Green
TB drug priced out of reach
Article
/ 2 March 2016

TB drug priced out of reach

A promising new TB drug is now on the market but doctors say it’s been priced out of reach.

By Faranaaz Parker
No image available
Article
/ 3 December 2014

Activists fear a pharmaceutical plot is at play

The department of trade and industry has yet to finalise patent reforms, raising questions that cheaper medication could be blocked intentionally.

By Amy Green
New drug policy is patently high risk
Article
/ 30 October 2014

New drug policy is patently high risk

There is widespread support for drastic change to patent laws when it comes to pharmaceuticals, but the results could be disastrous.

By Phillip De Wet and Sarah Wild
Letters to the editor: January 24 to 30 2014
Article
/ 23 January 2014

Letters to the editor: January 24 to 30 2014

M&G readers comment on comparisons of Nelson Mandela, Thabo Mbeki and Jacob Zuma, and say we need cool heads when it comes to pharmaceutical drugs.

By Letters
Editorial: Stop the rot of secret party funding
Article
/ 16 January 2014

Editorial: Stop the rot of secret party funding

We should welcome the arrival of US-style political lobbying in South Africa, done in public rather than in private.

By Editorial
Motsoaledi: Big pharma’s ‘satanic’ plot is genocide
Article
/ 16 January 2014

Motsoaledi: Big pharma’s ‘satanic’ plot is genocide

Health minister Aaron Motsoaledi is livid about a pharmaceutical company campaign he says will restrict access to crucial drugs.

By Phillip De Wet
PIC still mulling Adcock’s $1.3bn CFR deal
Article
/ 31 October 2013

PIC still mulling Adcock’s $1.3bn CFR deal

The pharmaceutical company Adcock’s biggest shareholder PIC says it has not yet made a decision about whether to support the takeover of CFR.

By Chris Spillane
No image available
Article
/ 11 September 2013

Battle on the horizon over intellectual property policy draft

Some have lauded the draft policy, saying it could make medication cheaper, but others say it is "unimpressive" and "almost contradictory".

By Mara Kardas-Nelson
No image available
Article
/ 10 September 2013

New policy gives generic medicines the upper hand

A draft intellectual property policy has been lauded by rights groups who say its repercussions on drug patents could make medicines more affordable.

By Staff Reporter
Create drugs, create self-reliance
Article
/ 6 September 2013

Create drugs, create self-reliance

A young pharmacist is driving a project to get Tanzania to make more of its own medicine.

By Mara Kardas-Nelson and Bhekisisa Team
Pharmaceutical giant regrets corporate misconduct
Article
/ 6 July 2012

Pharmaceutical giant regrets corporate misconduct

GlaxoSmithKline has been fined $3-billion after admitting to encouraging the prescription of unsuitable antidepressants to children.

By Staff Reporter
No image available
Article
/ 16 September 2011

Malema ‘pushed’ for payment for cronies

Julius Malema allegedly pressured staff at Limpopo’s department of health to pay out on multimillion-rand contracts.

By Fiona Forde
No image available
Article
/ 4 May 2009

The race is on for generic profits

Aspen, Africa’s largest drug manufacturer, has grown on its strength as a producer of generic drugs.

By Lynley Donnelly
No image available
Article
/ 28 January 2009

India orders probe after drugs found in water supplies

India said on Wednesday it has ordered a probe into the results of a study that found supposedly treated wastewater contained a cocktail of 21 drugs.

By Staff Reporter
No image available
Article
/ 22 September 2008

WHO warns against drugs from Sandoz SA plant

The WHO on Monday warned customers not to buy drugs made by Novartis’s Sandoz generics unit in SA after an inspection revealed more than 40 faults.

By Staff Reporter

MAIL & GUARDIAN

ABOUT

About
Contact
Advertise

SUBSCRIPTIONS

Subscribe
Newsletters

FOLLOW

WhatsApp Channel
Twitter
Facebook
YouTube
Instagram
LinkedIn
TikTok
Threads

FLAGSHIP EVENTS

200 Young South Africans
Power Of Women
Greening The Future

LEGAL & CORRECTIONS

Privacy Policy
Cookie Policy
Ethics & Social Media Policy

RESOURCES

Mail & Guardian Careers
Property for sale


Mail & Guardian

© 2025 The Mail & Guardian. All rights reserved.

  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }